Inhibitory action of berberine on glucose absorption

Yaoxue Xuebao

Volumn 38, Issue 12, 2003, Pages 911-914

  Pan, Guo yu ^a   Wang, Guang ji ^a   Sun, Jian guo ^a   Huang, Zhi jiang ^a   Zhao, Xiao chen ^a   Gu, Yi ^a   Liu, Xiao dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alpha glucosidase; Berberine; Caco 2 cell; Glucose absorption

Indexed keywords

ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; BERBERINE; GLUCOSE; MALTOSE; SUCRASE;

ANIMAL; ARTICLE; CELL STRAIN CACO 2; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; INTESTINE ABSORPTION; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ALPHA-GLUCOSIDASES; ANIMALS; BERBERINE; CACO-2 CELLS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; MALE; MALTOSE; RATS; RATS, SPRAGUE-DAWLEY; SUCRASE;

EID: 4444305180     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chung JG, Chen GW, Hung CF, et al. Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells [J]. Am J Chin Med, 2000, 28(2):227-238.
2. Ni YX, Yang J, Fan S. Clinical study on Jiang Tang San in treating non-insulin dependent diabetes mellitus patients [J]. Chin J Integrated Tradit Chin West Med, 1994, 14(11):650-652.
3. Pan GY, Wang CJ, Liu XD et al. The involvement of P-glycoprotein in berberine absorption [J]. Pharmacol Toxicol, 2002, 91:193-197.
4. Fu D, O'Neill RA. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography [J]. Anal Biochem, 1995, 227(2):337-384.
5. Xiong MQ, Zhu ZZ. The study of diabetis treatment and insulin resistance improvement hy Chinese Medicine [J]. Chin Tradit Med New Drugs Clin Pharmacol, 1994, 5(4):47-50.
6. Gao CR, Zhang JQ, Hung QL. Experimental study on berberin raised insulin sensitivity in insulin resistance rat models [J]. Chin J Integrated Tradit West Med, 1997, 17(3):162-164.
7. Yin J, Hu RM, Tang JF, et al. Glucose-lowering effects in vitro [J]. Acta Univ Med Second Shanghai, 2001, 21(5):425-427.
8. Shen MP, Sun Q, Wang H. Studies on the intravenous pharmacokinetics and oral absorbtion of berberine HCl in beagle dogs [J]. Chin Pharmacol Bull, 1993, 9(1):64-67.
9. Yumoto R, Murakami T, Nakamoto Y, et al. Transport of Rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds [J]. J Pharmacol Exp Ther, 1999, 289(1):149-155.
10. Cormet-Boyaka E, Huneau JF, Mordrelle A, et al. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors [J]. Antimicrob Agents Chemother, 1998, 42(10):2607-2611.
11. + -dependent sugar transport in Caco-2 cells and human fetal colon [J]. J Membr Biol, 1987, 99(2):113-125.
12. Rong W, Cai LS, Guo SB, et al. Glibenclamide co-administration with aspirin and berberin in the treatment of NIDDM [ J]. New Drugs Clin Rem, 1997, 16(2):109-110.
13. Campbell LK, Baker DE, Campbell RK. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus [J]. Ann Pharmacother, 2000, 34(11):1291-301.
14. Stermitz FR, Lorenz P, Tawara JN, et al. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′- methoxyhydnocarpin, a multidrug pump inhibitor [J]. Proc Natl Acad Sci USA, 2000, 97(4):1433-1437.